Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication

NACompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Bismuth quadruple therapy

pantoprazole 40 mg bid for 14 days, bismuth subcitrate 120 mg qid for 14 days, tetracycline 500 mg qid for 14 days, metronidazole 250 mg qid for 14 days

DRUG

Hybrid therapy

(pantoprazole 40 mg bid for 7 days, amoxicillin 1 g bid for 7 days) followed by (pantoprazole 40 mg bid for 7 days, amoxicillin 1 g bid for 7 days, clarithromycin 500 mg bid for 7 days, and metronidazole 500 mg bid for 7 days)

All Listed Sponsors
lead

Kaohsiung Veterans General Hospital.

OTHER

NCT02541864 - Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication | Biotech Hunter | Biotech Hunter